Radiation Therapy for Metastatic Spinal Disease Causing Back Pain
For uncomplicated spinal metastases causing back pain without neurological compromise or spinal instability, single-fraction radiotherapy of 8 Gy is as effective as multi-fraction regimens and should be your first-line treatment. 1
Treatment Selection Algorithm
Step 1: Assess Clinical Presentation and Urgency
Obtain MRI within specific timeframes based on symptoms:
- Local back pain only: within 2 weeks
- Unilateral radicular pain: within 1 week
- Progressive radicular deficit (>7 days): within 48 hours
- Progressive radicular deficit (<7 days): within 24 hours
- Suspected spinal cord compression: within 12 hours 2
Step 2: Determine Treatment Approach Based on Clinical Features
For uncomplicated bone metastases (no cord compression, no instability):
- Single-fraction: 8 Gy in 1 fraction is equivalent to multi-fraction regimens for pain relief 3, 1
- Alternative multi-fraction options: 20 Gy/5 fractions, 24 Gy/6 fractions, or 30 Gy/10 fractions 1
- Pain relief achieved in >75% of patients 4
Important caveat: Single-fraction therapy has higher re-irradiation rates and shorter duration of pain relief. Reserve multi-fraction regimens for patients with:
- Longer life expectancy (>6 months)
- Oligometastatic disease
- Adjacent soft tissue involvement 3
For spinal cord or cauda equina compression (without surgery):
- 8 Gy/1 fraction, 16 Gy/2 fractions, 20 Gy/5 fractions, or 30 Gy/10 fractions 1
- Add dexamethasone 10-16 mg bolus - this is mandatory, not optional 4, 1
- Single-fraction is generally avoided in epidural spinal cord compression 3
Step 3: Consider Surgery First in Specific Scenarios
Surgery followed by postoperative radiotherapy is superior to radiotherapy alone when:
- Spinal instability present (use SINS score as gold standard) 3, 2
- Life expectancy ≥3 months
- Spinal cord compression with good performance status
- Failure or progression after prior radiotherapy 2
After surgery, use conventional external beam RT with same fractionation schemes as above 1
Step 4: Special Populations
For oligometastatic disease (limited metastases, good prognosis):
- Consider stereotactic body radiotherapy (SBRT) with 24 Gy in 3 fractions for improved local control 3
- SBRT conditionally recommended over conventional RT in selected patients with good performance status, no neurological symptoms 1
- Some evidence suggests SBRT (24 Gy/2 fractions) provides superior pain relief compared to conventional EBRT (20 Gy/5 fractions), though this remains debated 3
For re-irradiation of previously treated spine metastases:
- 8 Gy/1 fraction, 20 Gy/5 fractions, 24 Gy/6 fractions, or 20 Gy/8 fractions 1
- Single-fraction re-irradiation is safe and effective for peripheral bone metastases 5
- Critical: Carefully calculate cumulative spinal cord dose to avoid radiation myelitis 4
Key Clinical Pitfalls to Avoid
Don't use plain x-rays, CT, or bone scans to exclude spinal metastases - full spinal MRI with T1 and T2 sequences is mandatory 2
Don't delay treatment in cord compression - treatment must start within 24 hours of diagnosis to preserve neurological function 2
Single-fraction therapy trade-offs: While convenient and equally effective for pain, it carries higher re-irradiation needs. For patients you expect to live >6 months, multi-fraction regimens may provide more durable pain control 3
Fracture risk with high-dose per fraction: SBRT carries 5.3% fracture rate at 1 year, highest with large volumes >100 cc 3. Prophylactic fixation should precede radiotherapy for long bones at high fracture risk 4
Pain flare: Occurs with high-dose per fraction radiotherapy - counsel patients and provide breakthrough analgesia 3
Evidence Quality Note
The 2026 guidelines 3 and 2024 ASTRO guideline 1 represent the most current evidence, superseding older recommendations. These consistently support single-fraction 8 Gy as equivalent to multi-fraction regimens for uncomplicated cases, based on multiple randomized trials and meta-analyses. The debate around SBRT superiority remains unresolved, with conflicting evidence on pain relief benefits 3.